KANDICE WALKER: Open Payments
NPI 1063811834 · BARTLETT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,937 in 159 payments from 39 companies in 2025. Trend: 2023 $3,396 · 2024 $3,429 · 2025 $3,937
Food & beverage: $3,277Consulting: $660
| Company | Payments | Amount |
|---|---|---|
| Stemline Therapeutics Inc. | 1 | $660 |
| Daiichi Sankyo Inc. | 14 | $351 |
| Merck Sharp & Dohme LLC | 12 | $281 |
| E.R. Squibb & Sons, L.L.C. | 16 | $278 |
| Janssen Biotech, Inc. | 9 | $196 |
| Gilead Sciences, Inc. | 9 | $193 |
| AstraZeneca Pharmaceuticals LP | 9 | $181 |
| Celgene Corporation | 6 | $158 |
| PFIZER INC. | 8 | $138 |
| GlaxoSmithKline, LLC. | 5 | $110 |
Products named: Orserdu, Enhertu, KEYTRUDA, Trodelvy, REBLOZYL, OPDIVO, EPKINLY, CABOMETYX.
Industry payments across TN — which companies pay providers there.
